Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Free Cholesterol to Total Lipids in Very Large HDL percentage

DARS1 · rs371309040

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−10, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 434,646 British ancestry individuals, 8,796 British Central/South Asian individuals, 6,573 British African individuals.

The effect Each copy of the G allele shifted the measure 0.02 % higher (95% confidence interval 0.02-0.02); p = 7 × 10−11.

Where it sits Chromosome 2, band 2q21.3 — inside DARS1.

What ClinVar records

Classification Benign for Hypomyelination with brain stem and spinal cord involvement and leg spasticity; criteria provided, multiple submitters, no conflicts (2 of 4 stars, 6 submitters), last evaluated 2026-02-03. ClinVar record 383416 NM_001349.4(DARS1):c.505-13T>C

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-11-01 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

AG
Korean KRGDB
A 84.0% · G 16.0%
Korean Korea4K
A 82.2% · G 17.8%
Japanese ToMMo
A 86.5% · G 13.5%
World gnomAD
A 80.7% · G 19.3%
World 1000 Genomes
A 77.7% · G 22.3%
World TOPMed
A 80.2% · G 19.8%

By ancestry gnomAD

East Asian
A 80.9% · G 19.1%
European (non-Finnish)
A 83.1% · G 16.9%
African / African American
A 80.1% · G 19.9%
South Asian
A 73.9% · G 26.1%
Admixed American (Latino)
A 76.0% · G 24.0%
Middle Eastern
A 58.8% · G 41.2%
Finnish
A 86.4% · G 13.6%
Ashkenazi Jewish
A 53.6% · G 46.4%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A No copy of the version the research linked to Free Cholesterol to Total Lipids in Very Large HDL percentage. This is the starting point the study compared everyone against.
A/G One copy of the version the research linked to Free Cholesterol to Total Lipids in Very Large HDL percentage. That is a smaller link than two copies.
G/G Two copies of the version the research linked to Free Cholesterol to Total Lipids in Very Large HDL percentage. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Free Cholesterol to Total Lipids in Very Large HDL percentage (rs371309040). MyGeneLog™. https://www.mygenelog.com/variants/rs371309040

← See all variants